Treatment with perispinal etanercept was performed at the Institute of Neurological Recovery on October 11, 2019, and October 16, 2019. Text, images and video © 2019, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid improvement in speech, chronic central post-stroke pain, and walking 10 years after stroke after perispinal etanercept treatment. Treatment by Edward Tobinick M.D., February 2019, at the INR in Boca Raton, Florida. strokebreakthrough.com 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid improvement in speech, aphasia, motor function and chronic post-stroke pain immediately following perispinal etanercept (PSE) treatment by Edward Tobinick M.D. Filmed January 2019 at the Institute of Neurological Recovery in Boca Raton, Florida. http://www.strokebreakthrough.com 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid neurological improvement 2.5 years after brain injury due to cardiac arrest following perispinal etanercept treatment. Treatment by Edward Tobinick M.D. at the INR in Boca Raton, Florida. Filmed December 6, 2018, 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Immediate improvement in central post-stroke pain, 3 years after stroke, following perispinal etanercept. Treatment and filming Oct 31, 2018 and Nov 7, 2018, INR Boca Raton. 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

From Glascow, Scotland, 1 week after treatment at the INR in Boca Raton, Florida, filmed in March 2018. Discussion with Edward Tobinick MD. Treatment was performed 8 years after stroke that caused intractable aphasia, hearing and sensory dysfunction and difficulty using the right hand (motor dysfunction) prior to treatment. A graphic illustration suggesting that chronic neuroinflammation, mediated by excess TNF in the brain, can reversibly inactivate brain circuits necessary for optimal brain function and connectivity.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Patient and father, from Iceland, discusses improvements 2 years after stroke. The stroke happened at age 17. Improvements discussed include: spasticity, left neglect, walking, speech, fatigue, and improved ability to swallow.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

The stroke was in February of 2016.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

60 Minutes Australia “Reverse Stroke”
23 min. version Copyright 2018 60 Minutes Australia and INR PLLC, all rights reserved

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.